| Year |
Citation |
Score |
| 2023 |
Saoudi A, Barberat S, le Coz O, Vacca O, Doisy Caquant M, Tensorer T, Sliwinski E, Garcia L, Muntoni F, Vaillend C, Goyenvalle A. Partial restoration of brain dystrophin by tricyclo-DNA antisense oligonucleotides alleviates emotional deficits in mice. Molecular Therapy. Nucleic Acids. 32: 173-188. PMID 37078061 DOI: 10.1016/j.omtn.2023.03.009 |
0.315 |
|
| 2022 |
Zarrouki F, Goutal S, Vacca O, Garcia L, Tournier N, Goyenvalle A, Vaillend C. Abnormal Expression of Synaptic and Extrasynaptic GABA Receptor Subunits in the Dystrophin-Deficient Mouse. International Journal of Molecular Sciences. 23. PMID 36293496 DOI: 10.3390/ijms232012617 |
0.331 |
|
| 2022 |
Joly F, Jeckel P, Kriebel M, Raut S, El Massioui N, Vaillend C, Johnson LR, Volkmer H, Doyère V. Disruption of Amygdala Tsc2 in Adolescence Leads to Changed Prelimbic Cellular Activity and Generalized Fear Responses at Adulthood in Rats. Cerebral Cortex (New York, N.Y. : 1991). PMID 35149865 DOI: 10.1093/cercor/bhab506 |
0.582 |
|
| 2020 |
Briatore F, Pregno G, Di Angelantonio S, Frola E, De Stefano ME, Vaillend C, Sassoè-Pognetto M, Patrizi A. Dystroglycan Mediates Clustering of Essential GABAergic Components in Cerebellar Purkinje Cells. Frontiers in Molecular Neuroscience. 13: 164. PMID 32982691 DOI: 10.3389/fnmol.2020.00164 |
0.351 |
|
| 2020 |
Aupy P, Zarrouki F, Sandro Q, Gastaldi C, Buclez P, Mamchaoui K, Garcia L, Vaillend C, Goyenvalle A. Long-Term Efficacy of AAV9-U7snRNA-Mediated Exon 51 Skipping in mdx52 Mice. Molecular Therapy. Methods & Clinical Development. 17: 1037-1047. PMID 32462052 DOI: 10.1016/J.Omtm.2020.04.025 |
0.363 |
|
| 2020 |
Barboni MTS, Vaillend C, Joachimsthaler A, Liber AMP, Khabou H, Roux MJ, Vacca O, Vignaud L, Dalkara D, Guillonneau X, Ventura DF, Rendon A, Kremers J. Rescue of Defective Electroretinographic Responses in Dp71-Null Mice With AAV-Mediated Reexpression of Dp71. Investigative Ophthalmology & Visual Science. 61: 11. PMID 32049345 DOI: 10.1167/Iovs.61.2.11 |
0.34 |
|
| 2020 |
Castillon C, Gonzalez L, Domenichini F, Guyon S, Da Silva K, Durand C, Lestaevel P, Vaillend C, Laroche S, Barnier JV, Poirier R. The intellectual disability PAK3 R67C mutation impacts cognitive functions and adult hippocampal neurogenesis. Human Molecular Genetics. PMID 31943058 DOI: 10.1093/Hmg/Ddz296 |
0.425 |
|
| 2019 |
Martucci LL, Amar M, Chaussenot R, Benet G, Bauer O, de Zélicourt A, Nosjean A, Launay JM, Callebert J, Sebrié C, Galione A, Edeline JM, de la Porte S, Fossier P, Granon S, ... Vaillend C, et al. A multiscale analysis in CD38 mice unveils major prefrontal cortex dysfunctions. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201800489R. PMID 30844310 DOI: 10.1096/Fj.201800489R |
0.332 |
|
| 2018 |
Chaussenot R, Amar M, Fossier P, Vaillend C. Dp71-Dystrophin Deficiency Alters Prefrontal Cortex Excitation-Inhibition Balance and Executive Functions. Molecular Neurobiology. PMID 30051354 DOI: 10.1007/S12035-018-1259-6 |
0.457 |
|
| 2018 |
Helleringer R, Le Verger D, Li X, Izabelle C, Chaussenot R, Belmaati-Cherkaoui M, Dammak R, Decottignies P, Daniel H, Galante M, Vaillend C. Cerebellar synapse properties and cerebellum-dependent motor and non-motor performance in Dp71-null mice. Disease Models & Mechanisms. PMID 29895670 DOI: 10.1242/Dmm.033258 |
0.434 |
|
| 2017 |
Relizani K, Griffith G, Echevarría L, Zarrouki F, Facchinetti P, Vaillend C, Leumann C, Garcia L, Goyenvalle A. Efficacy and Safety Profile of Tricyclo-DNA Antisense Oligonucleotides in Duchenne Muscular Dystrophy Mouse Model. Molecular Therapy. Nucleic Acids. 8: 144-157. PMID 28918017 DOI: 10.1016/J.Omtn.2017.06.013 |
0.328 |
|
| 2017 |
Aragón J, González-Reyes M, Romo-Yáñez J, Vacca O, Aguilar-González G, Rendón A, Vaillend C, Montañez C. Dystrophin Dp71 Isoforms Are Differentially Expressed in the Mouse Brain and Retina: Report of New Alternative Splicing and a Novel Nomenclature for Dp71 Isoforms. Molecular Neurobiology. PMID 28127699 DOI: 10.1007/S12035-017-0405-X |
0.304 |
|
| 2017 |
Vaillend C, Chaussenot R. Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice. Human Molecular Genetics. 26: 1041-1055. PMID 28087735 DOI: 10.1093/Hmg/Ddx013 |
0.442 |
|
| 2016 |
Miranda R, Laroche S, Vaillend C. Reduced neuronal density in the CA1 anterodorsal hippocampus of the mdx mouse. Neuromuscular Disorders : Nmd. PMID 27614574 DOI: 10.1016/J.Nmd.2016.08.006 |
0.468 |
|
| 2015 |
Miranda R, Nagapin F, Bozon B, Laroche S, Aubin T, Vaillend C. Altered social behavior and ultrasonic communication in the dystrophin-deficient mdx mouse model of Duchenne muscular dystrophy. Molecular Autism. 6: 60. PMID 26527530 DOI: 10.1186/S13229-015-0053-9 |
0.407 |
|
| 2015 |
Chaussenot R, Edeline JM, Le Bec B, El Massioui N, Laroche S, Vaillend C. Cognitive dysfunction in the dystrophin-deficient mouse model of Duchenne muscular dystrophy: A reappraisal from sensory to executive processes. Neurobiology of Learning and Memory. 124: 111-22. PMID 26190833 DOI: 10.1016/J.Nlm.2015.07.006 |
0.4 |
|
| 2015 |
Goyenvalle A, Griffith G, Babbs A, El Andaloussi S, Ezzat K, Avril A, Dugovic B, Chaussenot R, Ferry A, Voit T, Amthor H, Bühr C, Schürch S, Wood MJ, Davies KE, ... Vaillend C, et al. Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers. Nature Medicine. 21: 270-5. PMID 25642938 DOI: 10.1038/Nm.3765 |
0.339 |
|
| 2013 |
Morice E, Farley S, Poirier R, Dallerac G, Chagneau C, Pannetier S, Hanauer A, Davis S, Vaillend C, Laroche S. Defective synaptic transmission and structure in the dentate gyrus and selective fear memory impairment in the Rsk2 mutant mouse model of Coffin-Lowry syndrome. Neurobiology of Disease. 58: 156-68. PMID 23742761 DOI: 10.1016/J.Nbd.2013.05.016 |
0.693 |
|
| 2013 |
Vianello S, Yu H, Voisin V, Haddad H, He X, Foutz AS, Sebrié C, Gillet B, Roulot M, Fougerousse F, Perronnet C, Vaillend C, Matecki S, Escolar D, Bossi L, et al. Arginine butyrate: a therapeutic candidate for Duchenne muscular dystrophy. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 27: 2256-69. PMID 23430975 DOI: 10.1096/Fj.12-215723 |
0.345 |
|
| 2012 |
Perronnet C, Chagneau C, Blanc PL, Samson-Desvignes N, Mornet D, Laroche S, Porte SDL, Vaillend C. Upregulation of brain utrophin does not rescue behavioral alterations in dystrophin-deficient mice Human Molecular Genetics. 21: 2263-2276. PMID 22343141 DOI: 10.1093/Hmg/Dds047 |
0.415 |
|
| 2011 |
Dallérac G, Perronnet C, Chagneau C, Leblanc-Veyrac P, Samson-Desvignes N, Peltekian E, Danos O, Garcia L, Laroche S, Billard JM, Vaillend C. Rescue of a dystrophin-like protein by exon skipping normalizes synaptic plasticity in the hippocampus of the mdx mouse. Neurobiology of Disease. 43: 635-41. PMID 21624465 DOI: 10.1016/J.Nbd.2011.05.012 |
0.483 |
|
| 2011 |
Miranda R, Nudel U, Laroche S, Vaillend C. Altered presynaptic ultrastructure in excitatory hippocampal synapses of mice lacking dystrophins Dp427 or Dp71. Neurobiology of Disease. 43: 134-141. PMID 21397023 DOI: 10.1016/J.Nbd.2011.02.017 |
0.475 |
|
| 2010 |
Perronnet C, Vaillend C. Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies. Biomed Research International. 2010: 849426-849426. PMID 20625423 DOI: 10.1155/2010/849426 |
0.375 |
|
| 2010 |
Vaillend C, Perronnet C, Ros C, Gruszczynski C, Goyenvalle A, Laroche S, Danos O, Garcia L, Peltekian E. Rescue of a dystrophin-like protein by exon skipping in vivo restores GABAA-receptor clustering in the hippocampus of the mdx mouse. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1683-8. PMID 20588257 DOI: 10.1038/Mt.2010.134 |
0.442 |
|
| 2009 |
Daoud F, Candelario-Martínez A, Billard JM, Avital A, Khelfaoui M, Rozenvald Y, Guegan M, Mornet D, Jaillard D, Nudel U, Chelly J, Martínez-Rojas D, Laroche S, Yaffe D, Vaillend C. Role of mental retardation-associated dystrophin-gene product Dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions. Plos One. 4: e6574. PMID 19649270 DOI: 10.1371/Journal.Pone.0006574 |
0.508 |
|
| 2009 |
Miranda R, Sébrié C, Degrouard J, Gillet B, Jaillard D, Laroche S, Vaillend C. Reorganization of Inhibitory Synapses and Increased PSD Length of Perforated Excitatory Synapses in Hippocampal Area CA1 of Dystrophin-Deficient mdx Mice Cerebral Cortex. 19: 876-888. PMID 18794205 DOI: 10.1093/Cercor/Bhn135 |
0.483 |
|
| 2008 |
Vaillend C, Poirier R, Laroche S. Genes, plasticity and mental retardation. Behavioural Brain Research. 192: 88-105. PMID 18329113 DOI: 10.1016/J.Bbr.2008.01.009 |
0.377 |
|
| 2007 |
Poirier R, Jacquot S, Vaillend C, Soutthiphong AA, Libbey M, Davis S, Laroche S, Hanauer A, Welzl H, Lipp HP, Wolfer DP. Deletion of the Coffin-Lowry syndrome gene Rsk2 in mice is associated with impaired spatial learning and reduced control of exploratory behavior. Behavior Genetics. 37: 31-50. PMID 17033934 DOI: 10.1007/S10519-006-9116-1 |
0.424 |
|
| 2006 |
Peltekian E, Ros K, Goyenvalle A, Gruszczynski C, Vaillend C, Laroche S, Garcia L, Danos O. 898. Intracerebral Exon Skipping Restores Dystrophin Expression in CA1 Pyramidal Neurons of mdx Mice Molecular Therapy. 13: S346. DOI: 10.1016/J.Ymthe.2006.08.987 |
0.464 |
|
| 2004 |
Vaillend C, Billard J, Laroche S. Impaired long-term spatial and recognition memory and enhanced CA1 hippocampal LTP in the dystrophin-deficient Dmdmdx mouse Neurobiology of Disease. 17: 10-20. PMID 15350961 DOI: 10.1016/J.Nbd.2004.05.004 |
0.457 |
|
| 2002 |
Vaillend C, Billard J. Facilitated CA1 hippocampal synaptic plasticity in dystrophin-deficient mice: role for GABAA receptors? Hippocampus. 12: 713-717. PMID 12542223 DOI: 10.1002/Hipo.10068 |
0.52 |
|
| 2002 |
Vaillend C, Mason SE, Cuttle MF, Alger BE. Mechanisms of neuronal hyperexcitability caused by partial inhibition of Na+-K+-ATPases in the rat CA1 hippocampal region. Journal of Neurophysiology. 88: 2963-78. PMID 12466422 DOI: 10.1152/Jn.00244.2002 |
0.566 |
|
| 2002 |
Vaillend C, Rampon C, Davis S, Laroche S. Gene control of synaptic plasticity and memory formation: implications for diseases and therapeutic strategies. Current Molecular Medicine. 2: 613-28. PMID 12420801 DOI: 10.2174/1566524023361952 |
0.43 |
|
| 2002 |
Dutar P, Vaillend C, Viollet C, Billard JM, Potier B, Carlo AS, Ungerer A, Epelbaum J. Spatial learning and synaptic hippocampal plasticity in type 2 somatostatin receptor knock-out mice Neuroscience. 112: 455-466. PMID 12044463 DOI: 10.1016/S0306-4522(02)00074-X |
0.459 |
|
| 2000 |
Viollet C, Vaillend C, Videau C, Bluet-Pajot MT, Ungerer A, L'Héritier A, Kopp C, Potier B, Billard J, Schaeffer J, Smith RG, Rohrer SP, Wilkinson H, Zheng H, Epelbaum J. Involvement of sst2 somatostatin receptor in locomotor, exploratory activity and emotional reactivity in mice. The European Journal of Neuroscience. 12: 3761-70. PMID 11029646 DOI: 10.1046/J.1460-9568.2000.00249.X |
0.393 |
|
| 1999 |
Vaillend C, Ungerer A. Behavioral characterization of mdx3cv mice deficient in C-terminal dystrophins Neuromuscular Disorders. 9: 296-304. PMID 10407849 DOI: 10.1016/S0960-8966(99)00029-2 |
0.413 |
|
| 1999 |
Vaillend C, Ungerer A, Billard J. Facilitated NMDA receptor-mediated synaptic plasticity in the hippocampal CA1 area of dystrophin-deficient mice. Synapse. 33: 59-70. PMID 10380851 DOI: 10.1002/(Sici)1098-2396(199907)33:1<59::Aid-Syn6>3.0.Co;2-K |
0.487 |
|
| 1998 |
Vaillend C, Billard JM, Claudepierre T, Rendon A, Dutar P, Ungerer A. Spatial discrimination learning and CA1 hippocampal synaptic plasticity in mdx and mdx3cv mice lacking dystrophin gene products. Neuroscience. 86: 53-66. PMID 9692743 DOI: 10.1016/S0306-4522(98)00023-2 |
0.482 |
|
| 1995 |
Vaillend C, Rendon A, Misslin R, Ungerer A. Influence of dystrophin-gene mutation on mdx mouse behavior. I. Retention deficits at long delays in spontaneous alternation and bar-pressing tasks Behavior Genetics. 25: 569-579. PMID 8540895 DOI: 10.1007/Bf02327580 |
0.39 |
|
| Show low-probability matches. |